Research Article
Increased Expression of Serglycin in Specific Carcinomas and Aggressive Cancer Cell Lines
Figure 3
(a) Grade 2 and (b) grade 3 breast ductal carcinomas displaying strong granular, cytoplasmic serglycin immunoreactivity. (c) Grade 3 infiltrating breast carcinoma. Note that the tumor cells as well as chronic inflammatory and stroma cells show strong serglycin expression. (d) Section from a benign breast lesion showing that serglycin is expressed in the glands and the stroma. However, inflammatory cells display minimal serglycin positivity. Original magnifications 20x.
| (a) |
| (b) |
| (c) |
| (d) |